ADORA2B and hearing loss disorder: Intriguingly, recent mouse studies revealed that erythrocyte‐specific genetic ablation of Adora2b (Qiang et al. 2021) accelerates the early onset of age‐related hearing loss and cognitive decline (Qiang et al. 2021).